Clinical Trial Update: A Study of Mycobacterium w in Combination With Paclitaxel Plus Cisplatin in Advanced Non Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Mycobacterium w in combination with paclitaxel and cisplatin for advanced non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Mycobacterium w (Mycobacterium w)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Cadila Pharnmaceuticals | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: COMPLETED